Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis

James D. Chalmers

Division of Respiratory Medicine and Gastroenterology, University of Dundee, Dundee, United Kingdom

Pierre-Regis Burgel

Université Paris Cité, CNRS UMR 8104, Inserm U1016

Charles L. Daley

National Jewish Health, Denver

Anthony De Soyza

Population and Health Sciences Institute, NIHR Biomedical Research Centre for Aging, Newcastle University, Newcastle upon Tyne, United Kingdom

Charles S. Haworth

David Mauger

Michael R. Loebinger

Royal Brompton Hospital, London

Pamela J. McShane

Division of Pulmonary and Critical Care Medicine, University of Texas Health Science Center at Tyler, Tyler

Felix C. Ringshausen

Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany

Francesco Blasi

Michal Shteinberg

Pulmonary Institute and Cystic Fibrosis Center, Carmel Medical Center, Haifa, Israel

Kevin Mange

Insmed, Bridgewater, NJ

Ariel Teper

Insmed, Bridgewater, NJ

Carlos Fernandez

Insmed, Bridgewater, NJ

Migdalia Zambrano

Insmed, Bridgewater, NJ

Chunpeng Fan

Insmed, Bridgewater, NJ

Xiangmin Zhang

Equine Infectious Diseases and Lentiviruses Division, State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences

Mark L. Metersky

University of Connecticut School of Medicine, Farmington